GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Alkaloid AD Skopje (XMAE:ALK) » Definitions » EV-to-EBIT

Alkaloid AD Skopje (XMAE:ALK) EV-to-EBIT : 19.49 (As of May. 29, 2025)


View and export this data going back to . Start your Free Trial

What is Alkaloid AD Skopje EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Alkaloid AD Skopje's Enterprise Value is MKD39,201 Mil. Alkaloid AD Skopje's EBIT for the trailing twelve months (TTM) ended in Mar. 2025 was MKD2,011 Mil. Therefore, Alkaloid AD Skopje's EV-to-EBIT for today is 19.49.

The historical rank and industry rank for Alkaloid AD Skopje's EV-to-EBIT or its related term are showing as below:

XMAE:ALK' s EV-to-EBIT Range Over the Past 10 Years
Min: 8.31   Med: 13.53   Max: 22.89
Current: 19.49

During the past 13 years, the highest EV-to-EBIT of Alkaloid AD Skopje was 22.89. The lowest was 8.31. And the median was 13.53.

XMAE:ALK's EV-to-EBIT is ranked worse than
57.33% of 689 companies
in the Drug Manufacturers industry
Industry Median: 16.82 vs XMAE:ALK: 19.49

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Alkaloid AD Skopje's Enterprise Value for the quarter that ended in Mar. 2025 was MKD38,748 Mil. Alkaloid AD Skopje's EBIT for the trailing twelve months (TTM) ended in Mar. 2025 was MKD2,011 Mil. Alkaloid AD Skopje's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2025 was 5.19%.


Alkaloid AD Skopje EV-to-EBIT Historical Data

The historical data trend for Alkaloid AD Skopje's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alkaloid AD Skopje EV-to-EBIT Chart

Alkaloid AD Skopje Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14.48 17.78 15.20 14.79 20.88

Alkaloid AD Skopje Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.49 16.67 16.57 20.88 19.27

Competitive Comparison of Alkaloid AD Skopje's EV-to-EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, Alkaloid AD Skopje's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alkaloid AD Skopje's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Alkaloid AD Skopje's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Alkaloid AD Skopje's EV-to-EBIT falls into.


;
;

Alkaloid AD Skopje EV-to-EBIT Calculation

Alkaloid AD Skopje's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=39201.094/2011.092
=19.49

Alkaloid AD Skopje's current Enterprise Value is MKD39,201 Mil.
Alkaloid AD Skopje's EBIT for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was MKD2,011 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Alkaloid AD Skopje  (XMAE:ALK) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Alkaloid AD Skopje's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2025 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Mar. 2025 ) =EBIT / Enterprise Value (Q: Mar. 2025 )
=2011.092/38747.5
=5.19 %

Alkaloid AD Skopje's Enterprise Value for the quarter that ended in Mar. 2025 was MKD38,748 Mil.
Alkaloid AD Skopje's EBIT for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was MKD2,011 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Alkaloid AD Skopje EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Alkaloid AD Skopje's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Alkaloid AD Skopje Business Description

Traded in Other Exchanges
N/A
Address
Boulevard Aleksandar, Makedonski 12, Skopje, MKD, 1000
Alkaloid AD Skopje is engaged in producing and selling pharmaceutical, chemical and cosmetic products, as well as goods from the herbal origin. Its segments are Pharmaceuticals, Chemicals, Cosmetics and Botanicals. It derives maximum revenue from Pharmaceuticals products segment.